Inhaled Steroid Growth Effect Should Not Discourage First-Line Use - Cmte.
Executive Summary
Suppression of growth velocity in pediatric asthma patients should not discourage the first-line use of inhaled corticosteroids, FDA's Pulmonary & Allergy and Endocrine & Metabolism Drugs Advisory Committees determined July 31 at a joint meeting.